Association between chronic kidney disease and Alzheimer's disease: an update
- PMID: 32246323
- DOI: 10.1007/s11011-020-00561-y
Association between chronic kidney disease and Alzheimer's disease: an update
Abstract
It has been accepted that kidney function is connected with brain activity. In clinical studies, chronic kidney disease (CKD) patients have been found to be prone to suffering cognitive decline and Alzheimer's disease (AD). The cognitive function of CKD patients may improve after kidney transplantation. All these indicators show a possible link between kidney function and dementia. However, little is known about the mechanism behind the relation of CKD and AD. This review discusses the associations between CKD and AD from the perspective of the pathophysiology of the kidney and complications and/or concomitants of CKD that may lead to cognitive decline in the progression of CKD and AD. Potential preventive and therapeutic strategies for AD are also presented. Further studies are warranted in order to confirm whether the setting of CKD is a possible new determinant for cognitive impairment in AD.
Keywords: Alzheimer’s disease; Chronic kidney disease; Cognitive impairment.
Similar articles
-
The Vicious Consequences of Chronic Kidney Disease on Cognitive Impairment and Alzheimer's Disease.ACS Chem Neurosci. 2025 May 21;16(10):1847-1859. doi: 10.1021/acschemneuro.5c00050. Epub 2025 May 9. ACS Chem Neurosci. 2025. PMID: 40340356 Review.
-
Therapeutic impact of rHuEPO on abnormal platelet APP, BACE 1, presenilin 1, ADAM 10 and Aβ expressions in chronic kidney disease patients with cognitive dysfunction like Alzheimer's disease: A pilot study.Biomed Pharmacother. 2018 Aug;104:211-222. doi: 10.1016/j.biopha.2018.05.028. Epub 2018 May 15. Biomed Pharmacother. 2018. PMID: 29775888
-
Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.Exp Gerontol. 2017 Jan;87(Pt A):108-112. doi: 10.1016/j.exger.2016.11.012. Epub 2016 Dec 1. Exp Gerontol. 2017. PMID: 27916702
-
Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.PLoS One. 2020 Oct 9;15(10):e0239871. doi: 10.1371/journal.pone.0239871. eCollection 2020. PLoS One. 2020. PMID: 33036021 Free PMC article.
-
Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.Am J Kidney Dis. 2019 Dec;74(6):782-790. doi: 10.1053/j.ajkd.2019.05.017. Epub 2019 Aug 1. Am J Kidney Dis. 2019. PMID: 31378643 Free PMC article. Review.
Cited by
-
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.J Mol Med (Berl). 2023 Mar;101(3):201-222. doi: 10.1007/s00109-023-02289-5. Epub 2023 Feb 9. J Mol Med (Berl). 2023. PMID: 36757399 Free PMC article. Review.
-
Pathogenesis of Chronic Kidney Disease Is Closely Bound up with Alzheimer's Disease, Especially via the Renin-Angiotensin System.J Clin Med. 2023 Feb 12;12(4):1459. doi: 10.3390/jcm12041459. J Clin Med. 2023. PMID: 36835994 Free PMC article. Review.
-
Clonal haematopoiesis, ageing and kidney disease.Nat Rev Nephrol. 2024 Mar;20(3):161-174. doi: 10.1038/s41581-023-00778-x. Epub 2023 Oct 26. Nat Rev Nephrol. 2024. PMID: 37884787 Free PMC article. Review.
-
Associations of Blood and Cerebrospinal Fluid Aβ and tau Levels with Renal Function.Mol Neurobiol. 2023 Sep;60(9):5343-5351. doi: 10.1007/s12035-023-03420-w. Epub 2023 Jun 13. Mol Neurobiol. 2023. PMID: 37310581
-
GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight.Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023. Cells. 2022. PMID: 35805109 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical